We have reported that cyclic adenosine-3', 5'-monophosphate (cAMP), cAMP-N'-oxide, and certain 8-substituted derivatives of cAMP had significant in vitro antiviral activity (18) in a cell line derived from a human carcinoma of the nasopharynx (KB). More recently, we have also found that the 3', 5'-cyclic phosphate derivatives of 1-f3-D-arabinofuranosylcytosine (20) , 9- ,B-D-arabinofuranosyladenine (Sidwell et al., Chemotherapy, in press), and 1-f3-D-ribofuranosyl-1, 2, 4-triazole-3-carboxamide (Proc. 8th Int. Congr. Chemother., in press) have antiviral activity both in vitro and in vivo at least as extensive as the parent nucleosides. Zimmerman and Raska (22) have similarly demonstrated that dibutryl cAMP markedly inhibited the induction of deoxyribonucleic acid synthesis by type 12 adenovirus in vitro. These data have prompted us to examine other biologically active cyclic nucleotides as antiviral agents.
The synthesis of several 6-substituted derivatives of cAMP has been reported (4, 10, 12) . These compounds exhibited a variety of biological actions, as reviewed by Meyer et al. (10) , and appeared to be logical candidates for antiviral evaluation. Twelve 6-substituted derivatives of 9-fl-D-ribofuranosylpurine 3', 5'-cyclic phosphate (RPcMP) synthesized in our laboratory have subsequently been examined for in vitro antiviral activity, as described in this report.
MATERIALS AND METHODS Cells and growth media. Cells used in this study included 'primary chicken embryo, rabbit kidney, African green monkey kidney (Vero), and KB. The trypsinized cells were added to each well of micro tissue culture plates (Falcon Plastics, Oxnard, Calif.) in a concentration of 1.8 x 105 cells/ml in 0.2-ml volumes. Eagle minimal essential medium, supplemented with 10% heat-inactivated fetal bovine serum, 0.1 to 0.22% NaHCO3, 100 Ag of streptomycin per ml, and 100 U of penicillin per ml, was used as the growth medium. Eagle minimal essential medium containing the same antibiotics but 5% fetal bovine serum and 0.25% NaHCO. was used as the test medium. 8 rhinovirus strain CU-MRH, type 13 rhinovirus strain 353, and type 56 rhinovirus strain CH82 were used in these experiments. The sources of these viruses have been described previously (9) . The viruses were generally used in concentrations of 100 to 320 cell culture 50% infective doses per 0.2 ml.
Chemicals. The 12 compounds evaluated in these studies are shown in Fig. 1 In those experiments wherein significant CPE inhibition had been demonstrated, the total intra-and extracellular virus titer at each drug concentration after the 72-h incubation was also determined as an additional criterion for evaluating the antiviral activity of these compounds. These virus titers were determined by adding dilutions of the frozen and thawed cell and supernate from each pooled sample to the appropriate cell monolayers grown in microplates and measuring the 50% infectivity end point after a 72-h incubation of these indicator cells.
Cytotoxicity determinations. Cytotoxicity was measured by the degree of cell granularity, alteration of shape, size, and number of floating cells as discemed microscopically.
RESULTS
Among the 6-substituted derivatives studied, five (6-hydroxylamino-, 6-thio-, 6 methylthio-, 6-ethylthio-, and 6-benzylthio-RPcMP) exerted antiviral activity against one or more viruses. The antiviral experiments with each compound are summarized in Tables 1 through 6. Two HSV/1 experiments using the 6-hydroxylamino derivative are illustrated in Table 1 . In these experiments, the compound was added cCombined intra-and extracellular virus determined 3 days after exposure to virus. (Table 2 ). The 6-thio derivative ( with some granularity and altered shape seen in the presence of up to 100 Ag/ml. parainfluenza virus, but was ineffective against the other deoxyribonucleic acid and ribonucleic acid viruses employed in the study. The 6-methylthio derivative (Table 4) had activity against HSV/1, HSV/2, human cytomegalovirus, vaccinia virus, and types 1, 2, 8, and 13 rhinoviruses. Extending the 6-substitution to the ethylthio and benzylthio moieties (Tables 5 and 6 ) weakened the demonstrable anti-deoxyribonucleic acid virus activity, but a relatively strong effect was seen against the rhinoviruses.
The effects of 6-thio-, 6-methylthio-, 6-benzylthio-and 6-hydroxyl-amino-RPcMP on the cell and supernate HSV/1 titer are seen in Fig.  2 . The hydroxylamino derivative had the highest degree of activity by this parameter at high concentrations, with virus titer reduction of up to 5 log10 demonstrated; the methylthio derivative was more active at lower concentrations, however, with over 2 log10 reduction in virus seen. Figure 3 shows similar experiments using HSV/2. In this experiment the thio derivative was most active, particularly at lower concentrations, verifying the CPE inhibition data described above. The hydroxylamino derivative was only inhibitory at relatively toxic concentrations.
A timed study was carried out using the methylthio derivative against HSV/1, with the drug added 2 h pre-virus inoculation only, 2 h pre-and simultaneously with virus, simultaneously with virus, and 1, 3, or 5 h after exposure of the cells to the virus. CPE inhibition was Table 2 for abbreviations.
" Maximal tolerated dose in KB cells was 1.0 ,g/ml.
Cells were viable, although with some granularity and altered shape seen in the presence of up to 1,000 4g/ml. Cells were viable, although with some granularity and altered shape seen in the presence of up to 100 ,g/ml. determined 72 h later and is summarized in Fig.  4 . The greatest degree of activity occurred if the drug was added prior to the virus and allowed to remain on the cells for the duration of the experiment. Removal of the compound after a 2-h preincubation extensively reduced its antiviral effect. Post-virus treatment also resulted in significant antiviral activity, with the compound being active in concentrations as low as 10,ug/ml when added 24 h post-virus exposure.
Cytotoxicity studies with the five compounds having antiviral activity indicated the maximal tolerated (not discernibly toxic) dose to range from 0.32 ,g/ml for the methylthio derivative to 3.2 ,ug/ml for the benzylthio and hydroxylamino derivatives. The cells, however, were still viable, although with slight dose-dependent granularity or altered shape in the presence of 100 to 1,000 jug of the various active compounds per ml. DISCUSSION These experiments indicate that certain 6-substituted RPcMP derivatives can exert a significant viral inhibitory effect in vitro. This activity was demonstrable as both inhibition of virus-induced CPE and as reduction of intraand extracellular virus titer; the inhibition of virus production usually was still apparent at drug levels no longer inhibitory to CPE. These results, coupled with antiviral data seen in reported studies with other cyclic nucleotides (18, 20; Sidwell et al., Chemotherapy, in press; Sidwell et al., Proc. 8th Int. Congr. Chemother., in press) should further strengthen interest in such compounds as antiviral agents.
Two particular advantages of cyclic nucleotides over the parent nucleoside derivatives may be considered. First, since it has been reported that cAMP and the 3', 5'-cyclic phosphate of 9-fl-D-arabinofuranosyladenine may cross cell membranes (9, 13, 14) , the possibility of other cyclic nucleotides having this property appears to be reasonable. Hence, assuming the compounds are acting at the 5'-mono-, di-, or triphosphate level in the cell, as do other purine and pyrimidine nucleosides (1, 2, 5, 7, 21) , little additional alteration of the molecule would be required by the host system. Meyer et al. (10) have shown that hydrolysis of these compounds by the ubiquitous cyclic nucleotide phosphodiesterase is necessary to produce the 5'-monophosphate. These compounds are good substrates for that enzyme. Another advantage of the cyclic nucleotides lies in their possible increased stability to action by normal cellular enymes (20) .
The synthesis of N6-alkyl derivatives of cAMP was first described by Posternak et al. (12) . Those compounds acted as activators of cAMP-dependent protein kinase and stimulated the release of growth hormone and prolactin from anterior pituitary gland slices (3) . Later investigations with 6-substituted derivatives of RPcMP have shown them to be somewhat more stable than cAMP to enzymatic hydrolysis by brain or heart phosphodiesterases (11). Meyer et al. (10) have reported the 6-alkylthio derivatives used in the present study to be more active than cAMP as alternate activators of cAMP-dependent bovine brain protein kinase. The 6-thio derivative was less active than cAMP in this same system.
It is recognized that the cyclic nucleotides used in this study may have been cleaved to the 5'-monophosphate, since the medium used in these tests contained fetal calf serum which is known to have phosphodiesterase activity (8) . They may also have been dephosphorylated to the nucleoside or possibly even broken down to the parent base moiety. In a previous study, we have found purine 6-thiol and 9-fl-Dribofuranosylpurine-6-thiol to have marked activity against cytomegalovirus in vitro (15); 6-methylthio-9-/3-D-ribofuranosylpurine was inactive in this same study, however. The thiopurines are also inhibitory to the unrelated ribonucleic acid-containing Friend leukemia virus in vivo (19) , but were inactive against infections of vaccinia and influenza viruses in animals (16) .
Lengthening the 6-substituted grouping from methylthio to benzylthio obviously weakened the antiviral activity of the molecule. No explanation can be offered for the wide variation in spectrum of antiviral activity seen when minor alterations were made in this 6-substitution, except that the antiviral activity is apparently unrelated to the cAMP mimicking activity.
The timed-study run with the methylthio derivative suggests the drug to be of greatest efficacy when used prophylactically, hence suggesting that the compound is acting at an early stage in viral synthesis within the cell, presumably before viral assembly and release. Similar results have been seen with previously reported anti-cytomegalovirus studies with thiopurines (15) .
Planned follow-up studies include investigations of the in vivo antiviral activities of the cyclic nucleotides found active in vitro and studies on the antiviral activity of the base, ANTIMICROB. AG. CHEMOTHER. 
